Arca Biopharma Inc Share Price Nasdaq
Equities
US00211Y4070
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M 2.05B |
---|---|---|---|---|---|
Net income 2022 | -9M -751M | Net income 2023 | -5M -417M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M 3.51B | Net cash position 2023 | 37.15M 3.1B | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 01/06/01 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 10/21/10 |
Sharon Perry
LAW | General Counsel | - | 01/08/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 16/17/16 |
Robert Conway
CHM | Chairman | 70 | 03/13/03 |
Linda Grais
BRD | Director/Board Member | 68 | 01/07/01 |
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+23.35% | 27.87B | |
-17.74% | 20.95B | |
-15.73% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |